So if another researcher decided to pursue clinical trials of this same drug, they would have no idea about the dangers identified from the previous trial and would put more people at risk of the same adverse health effects that had already been identified so generally do you agree that it would be a good public health measure to ensure that results of all registered trials, regardless if the drug is approved or not, are posted on the database?
Markey emphasizes the need for transparency in clinical trial results to protect public health.
Share
More from Ed Markey
As with other efforts to erode federal civil rights oversight and enforcement, ED’s proposed rule is ‘like throwing away your umbrella in a rainstorm because you are not getting wet.’
We must also never forget that there are still more than five other Americans detained in Russia. I urge the Trump administration to use Robert’s case as motivation to continue to advocate for the release of others wrongfully detained in…
I will continue fighting for my Health Over Wealth Act and to get private equity out of health care.
One million square feet of new economic development for a new generation.
Other voices in this conversation
